Conclusions
HLT is a definitive treatment for end-stage cardiopulmonary failure. In
critically ill patients, VA-ECMO can be used to mitigate end-organ
dysfunction while awaiting suitable organs. Ambulatory Femoral VA-ECMO
cannulation seems to be safe and effective in carefully selected
patients and can mitigate many of the consequences related to ongoing
bedrest.